Immutep Limited PRRUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.71M | 9.38M | 5.15M | 4.19M | 3.28M |
| Total Other Revenue | -- | 3.00K | 5.90K | 5.90K | 5.90K |
| Total Revenue | 13.71M | 9.38M | 5.15M | 4.20M | 3.28M |
| Cost of Revenue | 62.37M | 57.84M | 53.43M | 46.38M | 39.61M |
| Gross Profit | -48.66M | -48.45M | -48.27M | -42.18M | -36.33M |
| SG&A Expenses | 6.47M | 6.41M | 6.35M | 5.95M | 5.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.84M | 64.25M | 59.78M | 52.33M | 45.21M |
| Operating Income | -55.13M | -54.87M | -54.63M | -48.13M | -41.92M |
| Income Before Tax | -53.58M | -53.86M | -54.16M | -46.73M | -39.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.58 | -53.86 | -54.16 | -46.73 | -39.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.58M | -53.86M | -54.16M | -46.73M | -39.55M |
| EBIT | -55.13M | -54.87M | -54.63M | -48.13M | -41.92M |
| EBITDA | -53.65M | -53.41M | -53.19M | -46.73M | -40.54M |
| EPS Basic | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 5.89B | 5.87B | 5.86B | 5.84B | 5.82B |
| Average Diluted Shares Outstanding | 5.89B | 5.87B | 5.86B | 5.84B | 5.82B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |